In the absence of progressive disease, standard therapy after surgery includes six courses of cisplatin or carboplatin + Cytoxan , or cisplatin + Taxol .
Investigational
• Intra-abdominal cisplatin or carboplatin or etoposide with or without other anticancer drugs.
• Intra-abdominal radioactive phosphate.
• Whole-abdomen and pelvic radiation therapy .
Stage IIa
Standard Treatment The surgical procedure is the same as for Stage Ic, again with biopsy of any suspicious lesions and washings of the abdominal cavity to check for malignant cells .
If all tumor implants are less than 3/4 in. (2 cm) in diameter after surgery, combination chemotherapy including cisplatin or carboplatin + Cytoxan is given to the majority of patients for six cycles (one course every three weeks).
Whole-abdomen and pelvic radiation may be given if the residual disease is less than 1/4 in. (0.5 cm) in diameter. Intra-abdominal radioactive phosphorus can be given if the residual disease is less than 1 mm in diameter.
